Atlas Trials

Boehringer Ingelheim

2,286 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Boehringer Ingelheim

RecordFirmDate
This Study Tests How Different Doses of BI 1291583 Are Taken up in the Body and How Well They Are Tolerated (NCT03414008)Boehringer Ingelheim2018-02-05
Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists (NCT03405363)Boehringer Ingelheim2018-01-31
This Study in Patients With Chronic Lymphocytic Leukaemia is Done to Determine a Safe and Effective Dose of BI 836826 in Combination With Venetoclax (NCT03343678)Boehringer Ingelheim2018-01-17
This Study Tests BI 1467335 in Healthy Male Volunteers. The Study Tests How Different Doses of BI 1467335 Are Taken up and Handled by the Body (NCT03382509)Boehringer Ingelheim2018-01-12
This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357 (NCT03279978)Boehringer Ingelheim2018-01-09
Afatinib Osimertinib Sequencing NIS (NCT03370770)Boehringer Ingelheim2017-12-28
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months (NCT03351244)Boehringer Ingelheim2017-12-07
This Study Observes the Use of New Oral Anticoagulants (NOACs) in Patients With a Heart Rhythm Disorder in Spain (NCT03285373)Boehringer Ingelheim2017-11-29
This Study Tests the Safety, Tolerability and How Different Doses of BI 1265162 Are Taken up in the Body of Healthy Men (NCT03349723)Boehringer Ingelheim2017-11-23
Real World Glycemic Effectiveness of Linagliptin (NCT03338803)Boehringer Ingelheim2017-11-21
This Study in Healthy Men Tests How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How BI 705564 Affects the Way the Body Breaks Down Midazolam (NCT03325712)Boehringer Ingelheim2017-11-17
This Study in Healthy Men Tests How Different Doses of BI 894416 Are Taken up in the Body and How Well BI 894416 is Tolerated (NCT03315936)Boehringer Ingelheim2017-11-02
Testing Afatinib in Combination With Pembrolizumab in Patients With Squamous Cell Carcinoma of the Lung (NCT03157089)Boehringer Ingelheim2017-11-02
This Study Tests the Effect of Certain Medicines on the Transport of Other Medicines in the Body of Healthy Men (NCT03307252)Boehringer Ingelheim2017-10-25
Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain (NCT03281200)Boehringer Ingelheim2017-10-24
This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses) (NCT03165227)Boehringer Ingelheim2017-10-17
A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 1467335 is Processed in the Body (NCT03302091)Boehringer Ingelheim2017-10-17
Comparative Effectiveness of Empagliflozin in the US (NCT03363464)Boehringer Ingelheim2017-10-16
Relative Bioavailability of BI 1015550 Following Oral Administration Under Fed and Fasted Conditions in Healthy Male Subjects (NCT03302078)Boehringer Ingelheim2017-10-16
Medical Need of OAC Reversal (NCT03254147)Boehringer Ingelheim2017-10-15
This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated (NCT03165240)Boehringer Ingelheim2017-10-05
This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year (NCT03230097)Boehringer Ingelheim2017-09-29
Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE] (NCT03265145)Boehringer Ingelheim2017-09-20
A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated. (NCT03238963)Boehringer Ingelheim2017-09-19
This Study Tests BI 685509 in Healthy Chinese and Japanese Men; the Study Tests How Different Doses of BI 685509 Are Taken up in the Body and How Well They Are Tolerated (NCT03259464)Boehringer Ingelheim2017-09-04
← Previous Next →

Track Boehringer Ingelheim automatically

Every clearance here is in the API, with alerts when new ones post.